Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”

Yu-Hang Ye, Shao-Lai Zhou

Clin Mol Hepatol. 2025;31(1):e90-e92. Published online November 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0998

View: 821 Download: 20

Editorial

Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”

Sergi Marco, Chiara Braconi

Clin Mol Hepatol. 2025;31(1):323-326. Published online October 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0932

View: 891 Download: 39 Crossref: 1

Original Article

Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma

Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Peng-Cheng Wang, Chu-Bin Luo, Rong-Qi Sun, Jia Fan, Jian Zhou, Zheng-Jun Zhou, Shao-Lai Zhou

Clin Mol Hepatol. 2024;30(4):914-928. Published online August 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0296

View: 2840 Download: 204 Web of Science: 2 Crossref: 4

4

Hepatocellular carcinoma with Lymphoid stroma: report of two cases

Hye-Jeong Choi, M.D., Joon Hyuck Choi, M.D.

Clin Mol Hepatol. 2008;14(3):394-398. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.394

View: 5333 Download: 38 Crossref: 3

Carcinoma with Predominant Lymphoid Stroma in Hepatobiliary System -Report of 2 Cases-

Hye Sook Min , Eun Shin , Ja June Jang

Clin Mol Hepatol. 2007;13(2):222-227. Published online January 1, 1970

View: 2865 Download: 30

1 |

Viewed By 10241	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7246	MAFLD: How is it different from NAFLD?
Viewed By 5239	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4725	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4679	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 208	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 103	Non-alcoholic fatty liver disease: Definition and subtypes

Search